Last data update: Jun 27, 2022 . (Total: 36948 Documents since 2020)
Records 1-5 (of 5 Records)
|Query Trace: JAK1[original query]>>JAK1[Gene]|
| Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium.
Zhan Ren-Zhi, et al. Acta biomaterialia 2021 3 0.
| JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.
Tuttle Kathryn D, et al. Cell reports 2020 11 0. (7) 108407
| The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.
Goker Bagca Bakiye, et al. Cytokine & growth factor reviews 2020 6 0.
| Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
Stebbing Justin, et al. EMBO molecular medicine 2020 5 0.
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.